Lista de obras - Cristina Montero-Conde - Dominio Público Uruguay

A novel candidate region linked to development of both pheochromocytoma and head/neck paraganglioma

article

Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.

artículo científico publicado en 2010

Association Study of 69 Genes in the Ret Pathway Identifies Low-penetrance Loci in Sporadic Medullary Thyroid Carcinoma

article

Biallelic TSC2 Mutations in a Patient With Chromophobe Renal Cell Carcinoma Showing Extraordinary Response to Temsirolimus

artículo científico publicado en 2018

Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy

scientific article published on 23 November 2018

Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer

artículo científico publicado en 2007

Determination of CYP2D6 gene copy number by multiplex polymerase chain reaction analysis

artículo científico publicado en 2009

Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel MTOR-Activating Mutation

artículo científico publicado en 2017

Gain-of-function mutations in DNMT3A in patients with paraganglioma

artículo científico publicado en 2018

Genetics of pheochromocytoma and paraganglioma in Spanish patients.

artículo científico publicado en 2009

Genome-wide analysis of Pax8 binding provides new insights into thyroid functions

artículo científico publicado en 2012

Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?

artículo científico publicado en 2006

Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing

artículo científico publicado en 2019

Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers.

artículo científico publicado en 2013

Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid Cancer

artículo científico publicado en 2017

Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma

artículo científico publicado en 2019

Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients

artículo científico publicado en 2007

Molecular characterisation of a common SDHB deletion in paraganglioma patients.

artículo científico publicado en 2007

Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information

artículo científico publicado en 2007

Multilayer OMIC Data in Medullary Thyroid Carcinoma Identifies the STAT3 Pathway as a Potential Therapeutic Target in RETM918T Tumors.

artículo científico publicado en 2016

Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis.

artículo científico publicado en 2010

Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer

artículo científico publicado en 2007

PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma

artículo científico publicado en 2019

PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics

artículo científico publicado en 2017

Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity

artículo científico publicado en 2010

Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.

artículo científico publicado en 2015

Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas

artículo científico publicado en 2019

Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas.

artículo científico publicado en 2013

Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas

artículo científico publicado en 2010

SDHC mutation in an elderly patient without familial antecedents.

artículo científico publicado en 2008

Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma

artículo científico publicado en 2004

Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine

artículo científico publicado en 2016

Targeted Sequencing Reveals Low-Frequency Variants in EPHA Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy.

artículo científico publicado en 2016

The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors

artículo científico publicado en 2009

Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene.

artículo científico publicado en 2017

Tumoral and tissue-specific expression of the major human beta-tubulin isotypes

artículo científico publicado en 2010

Lista de obras de Cristina Montero-Conde

A novel candidate region linked to development of both pheochromocytoma and head/neck paraganglioma

Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.

Association Study of 69 Genes in the Ret Pathway Identifies Low-penetrance Loci in Sporadic Medullary Thyroid Carcinoma

Biallelic TSC2 Mutations in a Patient With Chromophobe Renal Cell Carcinoma Showing Extraordinary Response to Temsirolimus

Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy

Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer

Determination of CYP2D6 gene copy number by multiplex polymerase chain reaction analysis

Exceptional Response to Temsirolimus in a Metastatic Clear Cell Renal Cell Carcinoma With an Early Novel MTOR-Activating Mutation

Gain-of-function mutations in DNMT3A in patients with paraganglioma

Genetics of pheochromocytoma and paraganglioma in Spanish patients.

Genome-wide analysis of Pax8 binding provides new insights into thyroid functions

Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?

Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing

Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers.

Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid Cancer

Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma

Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients

Molecular characterisation of a common SDHB deletion in paraganglioma patients.

Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information

Multilayer OMIC Data in Medullary Thyroid Carcinoma Identifies the STAT3 Pathway as a Potential Therapeutic Target in RETM918T Tumors.

Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis.

Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer

PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma

PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics

Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity

Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.

Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas

Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas.

Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas

SDHC mutation in an elderly patient without familial antecedents.

Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma

Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine

Targeted Sequencing Reveals Low-Frequency Variants in EPHA Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy.

The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors

Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene.

Tumoral and tissue-specific expression of the major human beta-tubulin isotypes